{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T18:38:14Z","timestamp":1788028694655,"version":"build-2784847793"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T00:00:00Z","timestamp":1525737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Anesth"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s00540-018-2501-0","type":"journal-article","created":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T10:58:25Z","timestamp":1525777105000},"page":"463-478","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Executive summary of the Clinical Guidelines of Pharmacotherapy for Neuropathic Pain: second edition by the Japanese Society of Pain Clinicians"],"prefix":"10.1007","volume":"32","author":[{"given":"Masahiko","family":"Sumitani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyoshi","family":"Hosokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sei","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,8]]},"reference":[{"key":"2501_CR1","first-page":"1","volume-title":"Guidelines for the Pharmacologic Management of Neuropathic Pain","author":"The committee for the Guidelines for the Pharmacologic Management of Neuropathic Pain","year":"2011","unstructured":"The committee for the Guidelines for the Pharmacologic Management of Neuropathic Pain. Guidelines for the Pharmacologic Management of Neuropathic Pain, 1st edn. Tokyo: Shinko Trading Press; 2011, pp.\u00a01\u2013102.","edition":"1"},{"key":"2501_CR2","first-page":"1","volume-title":"The Clinical Guidelines of Pharmacotherapy for Neuropathic Pain","author":"The committee for the Clinical Guidelines of Pharmacotherapy for Neuropathic Pain","year":"2016","unstructured":"The committee for the Clinical Guidelines of Pharmacotherapy for Neuropathic Pain. The Clinical Guidelines of Pharmacotherapy for Neuropathic Pain, 2nd edn. Tokyo: Shinko Trading Press; 2016, pp.\u00a01\u2013258.","edition":"2"},{"key":"2501_CR3","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1016\/j.pain.2011.06.017","volume":"152","author":"TS Jensen","year":"2011","unstructured":"Jensen TS, Baron R, Haanpaa M, Kalso E, Loeser JD, Rice AS, Treed RD. A new definition of neuropathic pain. Pain. 2011;152:2204\u20135.","journal-title":"Pain"},{"key":"2501_CR4","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1053\/eujp.2001.0259","volume":"5","author":"K Meyer-Rosberg","year":"2001","unstructured":"Meyer-Rosberg K, Kvamstrom A, Kinnman E, Gordh T, Nordfors LO, Kristofferson A. Peripheral neuropathic pain: a multidimensional burden for patients. Eur J Pain. 2001;5:379\u201389.","journal-title":"Eur J Pain"},{"key":"2501_CR5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10865-006-9085-0","volume":"30","author":"M Leeuw","year":"2007","unstructured":"Leeuw M, Goossens MEJB., Linton SJ, Crombez G, Boersma K, Vlaeyen JW. The fear-avoidance model of musculoskeletal pain: Current state of scientific evidence. J Behav Med. 2007;30:77\u201394.","journal-title":"J Behav Med"},{"key":"2501_CR6","first-page":"1227","volume":"34","author":"K Hanaoka","year":"2013","unstructured":"Hanaoka K, Ogawa S, Hotta N, Sato J, Kikuchi S, Tanahashi N, Katayama Y, Hosokawa T, Konno S, Suzuki N, Sekiguchi M, Yamamoto T, Sumitani M. Progress and future prospects for neuropathic pain treatment in Japan. A proposal from the expert consensus conference. Pain Clin. 2013;34:1227\u20131237 (Japanese literature).","journal-title":"Pain Clin"},{"key":"2501_CR7","unstructured":"Mersky H, Bogduk N (eds) Classification on chronic pain, second ed. IASP task force on taxonomy. Part III: pain terms, a current list with definitions and notes on usage. Seattle: IASP Press; 1994."},{"key":"2501_CR8","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00776-014-0567-6","volume":"19","author":"M Nakamura","year":"2014","unstructured":"Nakamura M, Nishiwaki Y, Sumitani M, Ushida T, Yamashita T, Konno S, Taguchi T, Toyama Y. Investigation of chronic musculoskeletal pain (3rd report): With special reference to the importance of neuropathic pain and psychogenic pain. J Orthop Sci. 2014;19:667\u201375.","journal-title":"J Orthop Sci"},{"key":"2501_CR9","first-page":"565","volume":"47","author":"S Ogawa","year":"2012","unstructured":"Ogawa S, Iseki M, Kikuchi S. A large-scale survey on chronic pain and neuropathic pain in Japan. J Jpn Clin Orthop Assoc. 2012;47:565\u201374. (Japanese literature).","journal-title":"J Jpn Clin Orthop Assoc"},{"key":"2501_CR10","doi-asserted-by":"publisher","first-page":"e68013","DOI":"10.1371\/journal.pone.0068013","volume":"8","author":"Y Matsubayashi","year":"2013","unstructured":"Matsubayashi Y, Takeshita K, Sumitani M, Oshima Y, Tonosu J, Kato S, Ohya J, Oichi T, Okamoto N, Tanaka S. Validity and reliability of the Japanese version of the PainDETECT questionnaire: a multicenter observational study. PLoS One. 2013;8:e68013.","journal-title":"PLoS One"},{"key":"2501_CR11","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.pain.2011.10.028","volume":"153","author":"MI Benneti","year":"2012","unstructured":"Benneti MI, Rayment C, Hjermstad M, Aass N, Caraceni A, Kaasa S. Prevalence and aetiology of neuropathic pain in cancer patients: A systematic review. Pain. 2012;153:359\u2013652.","journal-title":"Pain"},{"key":"2501_CR12","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1177\/0269216312464408","volume":"27","author":"C Rayment","year":"2012","unstructured":"Rayment C, Hjermstad MJ, Aass N, Kaasa S, Caraceni A, Strasser F, Heitzer E, Fainsinger R, Bennett MI, European Palliative Care Research Collaborative (EPCRC). Neuropathic cancer pain: prevalence, severity, analgesics and impact from the European Palliative Care Research Collaborative-Computerised Symptom Assessment study. Palliat Med. 2012;27:714\u201321.","journal-title":"Palliat Med"},{"key":"2501_CR13","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.2174\/1381612053507864","volume":"11","author":"CE Hulsebosch","year":"2005","unstructured":"Hulsebosch CE. From discovery to clinical trials: treatment strategies for central neuropathic pain after spinal cord injury. Curr Pharm Des. 2005;11:1411\u201320.","journal-title":"Curr Pharm Des"},{"key":"2501_CR14","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1212\/WNL.64.12_suppl_3.S21","volume":"64","author":"GA Irving","year":"2005","unstructured":"Irving GA. Contemporary assessment and management of neuropathic pain. Neurology. 2005;64:S21\u2013S27.","journal-title":"Neurology"},{"key":"2501_CR15","doi-asserted-by":"publisher","first-page":"s13","DOI":"10.1016\/S1754-3207(08)70058-0","volume":"2","author":"TS Jensen","year":"2008","unstructured":"Jensen TS. Pathophysiology of pain: from theory to clinical evidence. Eur J Pain. 2008;2:s13\u20137.","journal-title":"Eur J Pain"},{"key":"2501_CR16","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1517\/14656566.5.3.551","volume":"5","author":"RW Johnson","year":"2004","unstructured":"Johnson RW, Whitton TL. Management of herpes zoster (shingles) and postherpetic neuralgia. Expert Opin Pharmacother. 2004;5:551\u20139.","journal-title":"Expert Opin Pharmacother"},{"key":"2501_CR17","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s00125-005-1721-7","volume":"48","author":"S Tesfaye","year":"2005","unstructured":"Tesfaye S, Kempler P. Painful diabetic neuropathy. Diabetologia. 2005;48:805\u20137.","journal-title":"Diabetologia"},{"key":"2501_CR18","first-page":"1187","volume":"31","author":"S Ogawa","year":"2010","unstructured":"Ogawa S. Development of the neuropathic pain screening questionnaire for Japanese patients with chronic pain. Pain Clin. 2010;31:1187\u20131194 (Japanese literature).","journal-title":"Pain Clin"},{"key":"2501_CR19","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1111\/papr.12528","volume":"17","author":"T Isomura","year":"2017","unstructured":"Isomura T, Sumitani M, Matsudaira K, Kawaguchi M, Inoue R, Hozumi J, Tanaka T, Oshima H, Mori K, Takemoto S, Inui H, Tahara K, Yamagami R, Hayakawa K. Development of the Japanese version of the Leeds Assessment of the Neuropathic Symptoms and Signs Pain Scale (LANSS-J): Diagnostic Utility in a clinical setting. Pain Prac. 2017;17:800\u20137.","journal-title":"Pain Prac"},{"key":"2501_CR20","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.jclinepi.2015.03.010","volume":"68","author":"S Mathieson","year":"2015","unstructured":"Mathieson S, Maher CG, Terwee CB, Folly de Campos T, Lin CW. Neuropathic pain screening questionnaires have limited measurement properties: a systematic review. J Clin Epidemiol. 2015;68:957\u201366.","journal-title":"J Clin Epidemiol"},{"key":"2501_CR21","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1212\/01.wnl.0000282763.29778.59","volume":"70","author":"RD Treede","year":"2008","unstructured":"Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, Griffin JW, Hansson P, Hughes R, Nurmikko T, Serra J. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology. 2008;70:1630\u20135.","journal-title":"Neurology"},{"key":"2501_CR22","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2165\/00019053-200927020-00002","volume":"27","author":"AB O\u2019Connor","year":"2009","unstructured":"O\u2019Connor AB. Neuropathic pain: Quality-of-life impact, costs and cost effectiveness of therapy. Pharmacoeconomics. 2009;27:95\u2013112.","journal-title":"Pharmacoeconomics"},{"key":"2501_CR23","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1016\/j.pain.2011.09.014","volume":"152","author":"N Attal","year":"2011","unstructured":"Attal N, Lanteri-Minet M, Laurent B, Fermanian J, Bouhassira D. The specific disease burden of neuropathic pain: results of a French nationwide survey. Pain. 2011;152:2836\u201343.","journal-title":"Pain"},{"key":"2501_CR24","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.pain.2007.08.013","volume":"136","author":"D Bouhassira","year":"2008","unstructured":"Bouhassira D, Lanteri-Minet M, Attal N, Laurent B, Touboul C. Prevalence of chronic pain with neuropathic pain characteristics in the general population. Pain. 2008;136:380\u20137.","journal-title":"Pain"},{"key":"2501_CR25","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jpain.2007.09.005","volume":"9","author":"RH Dworkin","year":"2008","unstructured":"Dworkin RH, Turk DC, Wyrwich KW, Beaton D, Cleeland CS, Farrar JT, Haythornthwaite JA, Hertz S, Jadad AR, Jensen MP, Kellstein D, Kerns RD, Manning DC, Martin S, Max MB, McDermott MP, McGrath P, Moulin DE, Nurmikko T, Quessy S, Raja S, Rappaport BA, Rauschkolb C, Robinson JP, Royal MA, Simon L, Stauffer JW, Stucki G, Tollett J, von Stein T, Wallace MS, Wernicke J, White RE, Williams AC, Witter J, Wyrwich KW. Initiative on methods, measurement and pain assessment in clinical trials. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain. 2008;9:105\u201321.","journal-title":"J Pain"},{"key":"2501_CR26","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.pain.2003.08.001","volume":"106","author":"DC Turk","year":"2003","unstructured":"Turk DC, Dworkin RH, Allen RR, Bellamy N, Brandenburg N, Carr DB, Cleeland C, Dionne R, Farrar JT, Galer BS, Hewitt DJ, Jadad AR, Katz NP, Kramer LD, Manning DC, McCormick CG, McDermott MP, McGrath P, Quessy S, Rappaport BA, Robinson JP, Royal MA, Simon L, Stauffer JW, Stein W, Tollett J, Witter J. Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain. 2003;106:337\u201345.","journal-title":"Pain"},{"key":"2501_CR27","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","volume":"14","author":"NB Finnerup","year":"2015","unstructured":"Finnerup NB, Attal N, Haroutounian S, McNicol E, Baron R, Dworkin RH, Gilron I, Haanpaa M, Hansson P, Jensen TS, Kamerman PR, Lund K, Moore A, Raja SN, Rice AS, Rowbotham M, Sena E, Siddal P, Smith BH, Wallace M. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015;14:162\u201373.","journal-title":"Lancet Neurol"},{"key":"2501_CR28","first-page":"459","volume":"25","author":"MS Wallace","year":"2000","unstructured":"Wallace MS, Magnuson S, Ridgway B. Efficacy of oral mexiletine for neuropathic pain with allodynia: a double-blind, placebo-controlled, crossover study. Reg Anesth Pain Med. 2000;25:459 \u2013 67.","journal-title":"Reg Anesth Pain Med"},{"key":"2501_CR29","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1185\/03007990903047880","volume":"25","author":"R Baron","year":"2009","unstructured":"Baron R, Mayoral V, Leijon G, Binder A, Steigerwald I, Serpell M. 5% lidocaine plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study. Curr Med Res Opin. 2009;25:1663\u201376.","journal-title":"Curr Med Res Opin"},{"key":"2501_CR30","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1185\/03007995.2010.483675","volume":"26","author":"S Rehm","year":"2010","unstructured":"Rehm S, Binder A, Baron R. Post-herpetic neuralgia: 5% lidocaine medicated plaster, pregabalin, or a combination of both?: a randomized, open, clinical effectiveness study. Curr Med Res Opin. 2010;26:1607\u201319.","journal-title":"Curr Med Res Opin"},{"key":"2501_CR31","first-page":"141","volume":"17","author":"S Ogawa","year":"2010","unstructured":"Ogawa S, Suzuki M, Arakawa A, Araki S, Yoshiyama T. Efficacy and safety of pregabalin for post-herpetic neuralgia: A multicenter collaborative randomized placebo controlled double blind control study. J Jpn Soc Pain Clin. 2010;17:141\u201352 (Japanese literature).","journal-title":"J Jpn Soc Pain Clin"},{"key":"2501_CR32","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/j.1464-5491.2010.03152.x","volume":"28","author":"J Satoh","year":"2011","unstructured":"Satoh J, Yagihashi S, Baba M, Suzuki Y, Arakawa A, Yoshiyama T, Shoji S. Efficacy and safety of pregabalin for treating neuropathic pain associated with diabetic peripheral neuropathy: a 14-week, randomized, double-blind, placebo-controlled trial. Diabet Med. 2011;28:109\u201316.","journal-title":"Diabet Med"},{"key":"2501_CR33","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1212\/WNL.0b013e318281546b","volume":"80","author":"DD Cardenas","year":"2013","unstructured":"Cardenas DD, Nieshoff EC, Suda K, Goto S, Sanin L, Kaneko T, Sporn J, Parsons B, Soulsby M, Yang R, Whalen E, Scavone JM, Suzuki MM, Knapp LE. A randomized trial of pregabalin in patients with neuropathic pain due to spinal cord injury. Neurology. 2013;80:533\u20139.","journal-title":"Neurology"},{"key":"2501_CR34","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/j.2040-1124.2010.00073.x","volume":"2","author":"H Yasuda","year":"2011","unstructured":"Yasuda H, Hotta N, Nakao K, Kasuga M, Kashiawagi A, Kawamor R. Superiority of duloxetine to placebo in improving diabetic neuropathic pain: Results of a randomized controlled trial in Japan. J Diabet Invest. 2011;2:132\u20139.","journal-title":"J Diabet Invest"},{"key":"2501_CR35","doi-asserted-by":"publisher","first-page":"83","DOI":"10.7224\/1537-2073.2014-001","volume":"17","author":"TR Brown","year":"2015","unstructured":"Brown TR, Slee A. A randomized placebo controlled trial of duloxetine for central pain in multiple sclerosis. Int J MS Care. 2015;17:83\u20139.","journal-title":"Int J MS Care"},{"key":"2501_CR36","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1001\/jama.2013.2813","volume":"309","author":"EM Smith","year":"2013","unstructured":"Smith EM, Pang H, Cirrincione C, Fleishman S, Paskett ED, Ahles T, Bressler LR, Fadul CE, Knox C, Le-Lindgwister N, Gilman PB, Shapiro CL. Alliance for clinical trials in oncology. Effect of duloxetine on pain, function and quality of life among patients with chemotherapy-induced painful peripheral neuropathy. JAMA. 2013;309:1359\u201367.","journal-title":"JAMA"},{"key":"2501_CR37","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/ALN.0000000000000902","volume":"124","author":"RP Schukro","year":"2016","unstructured":"Schukro RP, Oehmke MJ, Geroldinger A, Heinze G, Kress HG, Pramhas S. Efficacy of duloxetine in chronic low back pain with a neuropathic pain component. Anesthesiology. 2016;124:150\u20138.","journal-title":"Anesthesiology"},{"key":"2501_CR38","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1212\/WNL.51.4.1166","volume":"51","author":"CPN Watson","year":"1998","unstructured":"Watson CPN, Vernich L, Chipman M, Reed K. Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial. Neurology. 1998;51:1166\u201371.","journal-title":"Neurology"},{"issue":"1","key":"2501_CR39","doi-asserted-by":"publisher","first-page":"CD011209","DOI":"10.1002\/14651868.CD11209.Pub2.Review","volume":"8","author":"S Derry","year":"2015","unstructured":"Derry S, Wiffen PJ, Aldington D, Moore RA. Nortriptyline for neuropathic pain in adults. Cochrane Databases Syst Rev. 2015;8(1):CD011209. \n                    https:\/\/doi.org\/10.1002\/14651868.CD11209.Pub2.Review\n                    \n                  .","journal-title":"Cochrane Databases Syst Rev"},{"key":"2501_CR40","first-page":"651","volume":"147","author":"H Yamamura","year":"1988","unstructured":"Yamamura H, Dan K, Wakasugi B, Kiyono S, Hyodo M, Totoki T, Shigematsu A, Ebihara A. Effects of neurotropin tablets on post-herpetic neuralgia: A placebo-controlled multicenter double blind study. J Clin Exp Med. 1988;147:651\u201364 (Japanese literature).","journal-title":"J Clin Exp Med"},{"key":"2501_CR41","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1212\/WNL.50.6.1842","volume":"50","author":"Y Harati","year":"1998","unstructured":"Harati Y, Gooch C, Swenson M, Edelman S, Greene D, Raskin P, Donofrio P, Comblath D, Sachdeo R, Siu CO, Kamin M. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology. 1998;50:1842 \u2013 184.","journal-title":"Neurology"},{"key":"2501_CR42","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0304-3959(99)00079-2","volume":"83","author":"SH Sindrup","year":"1999","unstructured":"Sindrup SH, Andersen G, Madsen C, Smith T, Brosen K, Jensen TS. Tramadol relieves pain and allodynia in polyneuropathy: a randomized, double-blind, controlled trial. Pain. 1999;83:85\u201390.","journal-title":"Pain"},{"key":"2501_CR43","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S0304-3959(03)00020-4","volume":"104","author":"F Boureau","year":"2003","unstructured":"Boureau F, Legallicier P, Kabir-Ahmadi M. Tramadol in post-herpetic neuralgia: A randomized, double-blind, placebo-controlled trial. Pain. 2003;104:323\u201331.","journal-title":"Pain"},{"key":"2501_CR44","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2165\/00044011-200727010-00007","volume":"27","author":"D Arbaiza","year":"2007","unstructured":"Arbaiza D, Vidal O. Tramadol in the treatment of neuropathic cancer pain: a double-blind, placebo-controlled study. Clin Drug Invest. 2007;27:75\u201383.","journal-title":"Clin Drug Invest"},{"key":"2501_CR45","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1002\/pds.1113","volume":"14","author":"TJ Cicero","year":"2005","unstructured":"Cicero TJ, Inciardi JA, Adams EH, Geller A, Senay EC, Woody GE, Munoz A. Rates of abuse of tramadol remain unchanged with the introduction of new branded and generic products: results of an abuse monitoring system, 1994\u20132004. Pharmacoepidemiol Drug Safe. 2005;14:851\u20139.","journal-title":"Pharmacoepidemiol Drug Safe"},{"key":"2501_CR46","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1155\/2004\/304094","volume":"9","author":"CPN Watson","year":"2004","unstructured":"Watson CPN, Watt-Watson JH, Chipman ML. Chronic non-cancer pain and the long term utility of opioids. Pain Res Manage. 2004;9:19\u201324.","journal-title":"Pain Res Manage"},{"key":"2501_CR47","doi-asserted-by":"publisher","first-page":"85","DOI":"10.7326\/0003-4819-152-2-201001190-00006","volume":"152","author":"KM Dunn","year":"2010","unstructured":"Dunn KM, Saunders KW, Rutter CM, Benta-Green CJ, Merrill JO, Sullivan MD, Weisner CM, Silverberg MJ, Campbell CI, Psaty BM, Von Korff M. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med. 2010;152:85\u201392.","journal-title":"Ann Intern Med"},{"key":"2501_CR48","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s10195-009-0077-z","volume":"10","author":"CL Romano","year":"2009","unstructured":"Romano CL, Romano D, Bonora C, Degrate A, Milneo G. Pregabalin, celecoxib, and their combination for treatment of chronic low-back pain. J Orthopaed Traumatol. 2009;10:185\u201391.","journal-title":"J Orthopaed Traumatol"}],"container-title":["Journal of Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00540-018-2501-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00540-018-2501-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00540-018-2501-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T23:50:30Z","timestamp":1557273030000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00540-018-2501-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,8]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["2501"],"URL":"https:\/\/doi.org\/10.1007\/s00540-018-2501-0","relation":{},"ISSN":["0913-8668","1438-8359"],"issn-type":[{"value":"0913-8668","type":"print"},{"value":"1438-8359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,8]]},"assertion":[{"value":"16 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Members of the task force have conflicts of interest with respect to this work, but none of them received any financial support to develop these guidelines. Astellas, Abott Japan, Eisai, MSD Japan, Elliquence, Otsuka Pharmacetical, Ono Pharmacetical, Kyowa Hakko Kirin Co., LTD., Sato Healthcare Innovation, Shionogi & Co., LTD., Showa Yakuhin Kako Co., LTD., St. Jude Medical Japan, Daiichi-Sankyo, Daiken Medical Co. LTD., Taisho Toyama Pharmacetical, Sumitomo Dainippon Pharma, Taiho Pharma, Takeda Pharmacetical, Mitsubishi Tanabe Pharma, Tsumura & Co., Teikoku Seiyaku, Terumo, Torii Pharmaceutical, Toray, Drager Medical Japan, Nipro, Eli Lilly Japan, Nippon Kayaku, Nippon Shinyaku Co., LTD., Nippon Zoki, Boehringer Ingelheim Japan, Hisamitsu Pharmaceutical, Bitakain Seiyaku KK., B. Braun Aesculap Japan, Pfizer Japan, Fujifilm sonosite Japan, Boston Scientific Japan, Maruishi Pharmaceutical, Maruho, Mundipharma, Mochida Pharmaceutical, Janssen Pharmacetical KK.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}